Plant Engineering Evonik Completes Expansion of Methionine Production Units in Singapore

Source: Press release Evonik 2 min Reading Time

Related Vendors

Evonik has successfully completed the expansion of its methionine production facilities in Singapore. With this, the firm has increased its production capacity by 40,000 metric tons, bringing the total to 340,000 metric tons per year.

The expansion of the production facilities was inaugurated during a festive ceremony attended by Grace Fu, Singapore’s Minister for Sustainability and the Environment and Minister-in-Charge of Trade Relations.(Source:  Evonik)
The expansion of the production facilities was inaugurated during a festive ceremony attended by Grace Fu, Singapore’s Minister for Sustainability and the Environment and Minister-in-Charge of Trade Relations.
(Source: Evonik)

Essen/Germany – The expansion of Evonik’s Metamino (DL-methionine) production facilities in Singapore has been completed. The Metamino production on Jurong Island is again running at full capacity, after shutdowns in Q4/2023 and Q2/2024. The production capacity has been increased by 40,000 metric tons, bringing the total to 340,000 metric tons per year. The expansion was accomplished ahead of schedule.

Through process intensification, Evonik has optimized its methionine production plants, generating a surplus of steam that is used to produce on-site electricity.

Linde, one of Evonik's partners on Jurong Island, has designed, constructed, and is operating a nine-megawatt alkaline electrolyzer plant, which is the largest of its kind ever installed in Singapore. The unit enables Evonik's efforts to use green hydrogen required for the Metamino production and reflects the company's commitment to sustainability and reducing its environmental impact.

“Our collaboration with Linde on the implementation of green hydrogen in our Singapore facilities is a testament to our commitment to sustainability. We work closely with our partners to build a more sustainable future," says Dr. Harald Schwager, Deputy Chairman of the Executive Board.

Evonik's DL-methionine plants in Singapore have reduced the product carbon footprint of Metamino at this site (Scope 1+2+3) by six percent compared to before the expansion.

Stay up to Date

Do you want the latest news, specialist articles and information on new products? Then you can register for our free newsletter:

Choose your Newsletter

The expansion of the Metamino production facilities was inaugurated during a festive ceremony attended by Grace Fu, Singapore’s Minister for Sustainability and the Environment and Minister-in-Charge of Trade Relations: “Evonik's latest expansion will help address two urgent problems – climate change and food production – in a sustainable way. By increasing its product yield with fewer emissions, Evonik's facility will help to feed a growing population while streamlining our carbon footprint. Congratulations to Evonik for paving the way to a more sustainable future,” said Minister Fu.

In 2023, Evonik set its own science-based targets that have been approved by the Science Based Targets Initiative as consistent with a well-below 2°C (WB2C) pathway. “We are committed to reducing emissions in line with the latest climate science, and consequently, we have a long-term ambition to expand our targets to align with a 1.5°C warming pathway, and reach net-zero emissions by 2050”, says Gaetano Blanda, head of the Animal Nutrition business line.

Metamino is used in livestock production to feed animals healthily, efficiently, and sustainably. With its science-based approach, the Animal Nutrition business line of Evonik develops products, services and system solutions that help supply a growing world population with healthy, high-quality and affordable animal protein. Animal Nutrition is part of Evonik's Nutrition & Care division and contributes significantly to the profitable growth of Nutrition & Care through its self-financing power.

(ID:50146689)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent